Kazia Therapeutics Limited Gains 81.53%
Wed, Jun 11, 2025 at 07:25 PM
Kazia Therapeutics Limited (KZIA:NASDAQ) shot up at $9.54, representing a gain of 81.5%. On Wed, Jun 11, 2025, KZIA:NASDAQ hit a New 2-Week High of $9.54. The stock got featured on our News Catalysts scanner on Wed, Jun 11, 2025 at 10:47 AM in the 'BIOTECH' category. From Wed, May 28, 2025, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Wed, Jun 11, 2025 at $12.86 with a volume of 49M+.
About Kazia Therapeutics Limited (KZIA:NASDAQ)
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.
Top 10 Gainers:
- Catheter Precision, Inc. (VTAK:NYSEMKT), 165.06%
- Jupiter Neurosciences, Inc. (JUNS:NASDAQ), 105.79%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 81.53%
- 707 Cayman Holdings Limited (JEM:NASDAQ), 73.07%
- XTI Aerospace, Inc. (XTIA:NASDAQ), 65.57%
- Distoken Acquisition Corporation (DIST:NASDAQ), 64.17%
- Kindly MD Inc. (NAKA:NASDAQ), 58.1%
- Nuwellis, Inc. (NUWE:NASDAQ), 57.56%
- INNEOVA Holdings Limited (INEO:NASDAQ), 53.45%
- mF International Limited (MFI:NASDAQ), 46.32%